Medical Weight-Management Program

Doctor-led weight-management program built around four pillars — nutritional consultation, GLP-1-class appetite regulation ('Slimming Pen'), supplemental fat-dissolving injections (Diamond Fat) for localized pockets, and Tesla Sculptor / Cool Slim for body contouring once weight is stable. The program emphasizes sustainable weight reduction over crash diets and integrates with the clinic's IV Fat Burn drip menu.

Gen Z Clinic's Weight-Management Program is structured around the modern medical evidence: that obesity is a chronic, relapsing condition driven by hormones (leptin, ghrelin, GLP-1 tone) more than willpower, and that durable success requires medical regulation of appetite alongside lifestyle change. The program runs in three phases: PHASE 1 — ASSESSMENT (visit 1) • Comprehensive medical history (thyroid, PCOS, cushing screening, mental health screening, medication review) • Body composition: weight, height, BMI, waist circumference, optionally bioimpedance • Goal-setting: realistic targets — 5–10% weight reduction in the first 3 months, with body-recomposition emphasis afterward • Pre-program lab work as indicated: fasting glucose, HbA1c, lipid panel, liver / kidney function, thyroid panel PHASE 2 — APPETITE REGULATION (months 1–6) • 'Slimming Pen' — once-weekly subcutaneous GLP-1-class agonist, dose-titrated upward to balance appetite reduction against side-effect tolerance. Acts on hypothalamic satiety centers and slows gastric emptying. • Nutritional protocol — high-protein, moderate-carb, fibre-emphasized framework with weekly check-ins • Optional IV Fat Burn drip — L-carnitine + B-complex + magnesium adjunct, 1–2x weekly PHASE 3 — CONTOURING & MAINTENANCE (month 6+) • Once weight is stable, Cool Slim for stubborn pockets that diet/medication alone won't shift • Tesla Sculptor for muscle redevelopment and core tone • Diamond Fat (premium fat-dissolving injection) for face and small focal areas • Tapering Slimming-Pen dose with relapse-prevention strategy (the modern evidence is clear that abrupt discontinuation produces 50–70% rebound; tapering + lifestyle locks the loss) Who is appropriate: BMI > 27 with metabolic risk, or BMI > 30 outright. Not appropriate for: pregnancy / breastfeeding, type-1 diabetes, history of pancreatitis, history of medullary thyroid carcinoma, MEN-2. The displayed price is for the initial consultation + first-month medication titration. Ongoing months are quoted by dose escalation.